• LAST PRICE
    2.4900
  • TODAY'S CHANGE (%)
    Trending Down-0.3000 (-10.7527%)
  • Bid / Lots
    2.4600/ 3
  • Ask / Lots
    3.0200/ 4
  • Open / Previous Close
    2.8100 / 2.7900
  • Day Range
    Low 2.4600
    High 2.9050
  • 52 Week Range
    Low 2.0000
    High 11.9900
  • Volume
    112,160
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.79
TimeVolumeOLMA
09:32 ET1052.81
09:37 ET2002.905
09:51 ET1002.8
09:55 ET114182.6
09:57 ET1202.6
10:11 ET2002.6
10:15 ET1002.62
10:26 ET2002.61
10:27 ET2802.6
10:29 ET1002.68
10:33 ET4002.65
10:36 ET1502.6584
10:38 ET1002.66
10:47 ET1002.65
11:12 ET1002.62
11:14 ET2002.61
11:30 ET1002.6
11:38 ET1002.61
11:52 ET9082.61
11:56 ET1002.61
12:03 ET28702.64
12:06 ET4002.64
12:08 ET144032.56
12:12 ET7212.55
12:19 ET1002.56
12:21 ET1002.54
12:24 ET1002.555
12:28 ET1002.56
12:30 ET1002.56
12:32 ET1972.53
12:37 ET2002.555
12:46 ET1002.555
12:50 ET7332.54
01:00 ET2002.5601
01:08 ET1002.555
01:15 ET1002.55
01:18 ET1002.56
01:24 ET1002.53
01:29 ET7962.53
01:31 ET5002.53
01:33 ET1002.55
01:40 ET1002.53
01:54 ET1002.55
01:56 ET1002.53
01:58 ET1002.55
02:00 ET136082.47
02:02 ET3892.46
02:05 ET186032.47
02:12 ET1002.5
02:14 ET7342.5
02:20 ET13152.49
02:27 ET1002.5
02:32 ET1002.49
02:36 ET1002.505
02:38 ET1002.49
02:39 ET2002.5
02:41 ET8022.49
02:50 ET1002.495
02:52 ET23882.47
02:54 ET8642.48
02:56 ET6002.48
02:57 ET3692.49
02:59 ET1312.49
03:01 ET2352.49
03:03 ET1532.49
03:06 ET2862.49
03:08 ET3002.5
03:15 ET1002.505
03:17 ET1002.505
03:21 ET2002.505
03:24 ET1002.49
03:26 ET1002.505
03:32 ET1002.505
03:33 ET20222.5
03:35 ET7202.495
03:37 ET4492.495
03:46 ET12002.49
03:48 ET2002.495
03:50 ET3322.495
03:51 ET1002.48
03:53 ET13702.5019
03:55 ET2832.495
03:57 ET2002.48
04:00 ET26012.49
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOLMA
Olema Pharmaceuticals Inc
112.9M
-1.0x
---
United StatesATHA
Athira Pharma Inc
111.2M
-1.4x
---
United StatesENZC
Enzolytics Inc
114.8M
-0.4x
---
United StatesNVCT
Nuvectis Pharma Inc
111.0M
0.0x
---
United StatesIFRX
InflaRx NV
110.5M
-2.9x
---
United StatesALZN
Alzamend Neuro Inc
106.9M
-8.1x
---
As of 2022-12-06

Company Information

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. It is designed based on a structural understanding of the ER. OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase four and six (CDK4/6) demonstrated robust tumor shrinkage in several xenograft models, including a breast cancer brain metastasis model. It is in the Phase I/ IIclinical trial, and in Phase I combination with palbociclib, in patients with metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

Contact Information

Headquarters
512 2Nd Street, 4Th Floor, Suite 250SAN FRANCISCO, CA, United States 94107
Phone
415-742-8265
Fax
302-674-5266

Executives

Independent Chairman of the Board
Ian Clark
President, Chief Executive Officer, Director
Sean Bohen
Co-Founder, Non-Executive Director, Senior Research Fellow
Peter Kushner
Chief Financial Officer, Chief Operating Officer
Shane Kovacs
Executive Vice President, Company Secretary, Chief Legal Officer
John Moriarty

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$112.9M
Revenue (TTM)
$0.00
Shares Outstanding
40.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.51
Book Value
$7.15
P/E Ratio
-1.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.